Correspondence 0001558370-23-019789 from SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC.
Date: Dec. 14, 2023 · CIK: 0000812796 · Accession: 0001558370-23-019789
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274265
Letter
Soligenix, Inc.
29 Emmons Drive, Suite B-10
Princeton, NJ 08540
December 14, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re:
Soligenix, Inc.
Registration Statement on Form S-3
Commission File No. 333-274265
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933 and on behalf of Soligenix, Inc. (the “Company”), the undersigned hereby requests that the Company’s Registration Statement on Form S-3 (Commission File No. 333-274265) filed with the U.S. Securities and Exchange Commission (the “Commission”) on August 30, 2023, as amended by Amendment No. 1 to Form S-3 Registration Statement filed with the Commission on December 8, 2023, be declared effective on December 15, 2023, at 4:00 p.m., Eastern Standard Time, or as soon as practicable thereafter.
Very truly yours,
SOLIGENIX, INC.
Show Raw Text
CORRESP 1 filename1.htm Soligenix, Inc. 29 Emmons Drive, Suite B-10 Princeton, NJ 08540 December 14, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Soligenix, Inc. Registration Statement on Form S-3 Commission File No. 333-274265 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933 and on behalf of Soligenix, Inc. (the “Company”), the undersigned hereby requests that the Company’s Registration Statement on Form S-3 (Commission File No. 333-274265) filed with the U.S. Securities and Exchange Commission (the “Commission”) on August 30, 2023, as amended by Amendment No. 1 to Form S-3 Registration Statement filed with the Commission on December 8, 2023, be declared effective on December 15, 2023, at 4:00 p.m., Eastern Standard Time, or as soon as practicable thereafter. Very truly yours, SOLIGENIX, INC. By: /s/ Christopher J. Schaber Christopher J. Schaber, PhD President and Chief Executive Officer cc: Driscoll R. Ugarte, P.A. Duane Morris LLP